• Non ci sono risultati.

Scarica il programma

N/A
N/A
Protected

Academic year: 2022

Condividi "Scarica il programma"

Copied!
1
0
0

Testo completo

(1)

Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO)

PROGRAM

si ringrazia per il contributo incondizionato:

ADVANCES IN THE TREATMENT OF GASTROINTESTINAL AND

NEURO-ENDOCRINE NEOPLASMS

CINBO

La partecipazione è gratuita.

Per accedere al Webinar collegarsi a www.strategieonweb.it/fad/

L’attestato di attribuzione dei crediti ottenuti, sarà inviato ai partecipanti, dopo aver verificato il completamento del percorso formativo ed il superamento della verifica di apprendimento.

May 20-21, 2021

PROVIDER ECM ID. 50 PROVIDER ECM ID. 50 ORGANIZING ORGANIZING SECRETARIAT SECRETARIAT

Via Piave 110/7 - Pescara Phone: +39 085 74143

Fax +39 085 378220 info@strategieonweb.it www.strategieonweb.it

OFFICES OFFICES

Consorzio Interuniversitario Nazionale

per la Bio-Oncologia (CINBO) c/o Sezione di Oncologia Medica Università G. D’Annunzio

Via dei Vestini, 31 66100 Chieti - Italy Phone: +39 0871 3556732 Fax +39 0871 3556707 cinbo@unich.it

Con il patrocinio di:

Evento n. ECM 50-318451 Per Medico Chirurgo specialisti in:

ALLERGOLOGIA ED IMMUNOLOGIA CLINICA; GASTROENTEROLOGIA; GENETICA MEDICA;

ONCOLOGIA; RADIOTERAPIA; CHIRURGIA GENERALE; ANATOMIA PATOLOGICA;

MEDICINA NUCLEARE; RADIODIAGNOSTICA; Per Farmacisti (Farmacia ospedaliera); Per Biologi.

Crediti ECM: 6

WEBINAR

Directors Directors Corrado Ficorella Clara Natoli Nicola Tinari

Test ECM sarà su piattaforma on line a partire dalle 24h dal termine del corso e resterà attivo per 48h su www.strategieonweb.it/fad/

May 21, 2021

13.00 Open on website www.strategieonweb.it/fad/

SESSION I SESSION I

GASTROINTESTINAL NEUROENDOCRINE NEOPLASMS GASTROINTESTINAL NEUROENDOCRINE NEOPLASMS Moderators: Nicola D’Ostilio, Corrado Ficorella 14.10 Relevance of the new classification system

of Gastrointestinal Neuroendocrine Neoplasms Massimo Milione, Milan

14. 30 Therapeutic algorithms in metastatic NEN Maria Teresa Martino, Chieti

14.50 Questions and answers SESSION II

SESSION II

HEPATOCELLULAR CARCINOMA HEPATOCELLULAR CARCINOMA Moderators: Daniele Santini, Nicola Tinari

15.00 Update on antiviral treatment of Hepatitis C virus Jacopo Vecchiet, Chieti

15.20 Pathology and molecular biology Fiamma Buttitta, Chieti

15.40 Locoregional treatments of HCC Alberto Giammarino, Chieti 16.00 HCC: First line treatment and beyond

Pietro Di Marino, Chieti 16.20 Questions and answers SESSION III

SESSION III

COLORECTAL CANCER COLORECTAL CANCER

Moderators: Clara Natoli, Dimitri Luisi

16.40 New perspectives in neoadjuvant treatment of rectal cancer

Domenico Genovesi, Chieti

17.00 BRAF-mutant metastatic colon cancer:

the best treatment options Andrea Sartore-Bianchi, Milan 17.20 Sequencing of treatment in metastatic

colorectal cancer: open issues Jessica Lucchetti, Rome 17.40 Questions and answers 17.50 - 18.00

Concluding remarks

Corrado Ficorella, Clara Natoli & Nicola Tinari

May 20, 2021

14.00 Open on website www.strategieonweb.it/fad/

15:00 Welcome and Introduction

Corrado Ficorella, Clara Natoli, & Nicola Tinari SESSION I

SESSION I

PANCREATIC CANCER PANCREATIC CANCER

Moderators: Pierluigi Di Sebastiano, Corrado Ficorella 15.10 Locally advanced pancreatic cancer:

a multidisciplinary approach Michele Reni, Milan

15.30 Treatment strategies for metastatic pancreatic cancer

Nicola Tinari, Chieti 15.50 Questions and answers SESSION II

SESSION II

ESOPHAGEAL AND GASTRIC CANCERS ESOPHAGEAL AND GASTRIC CANCERS Moderators: Giuseppe Tonini, Katia Cannita

16.00 Progress in multidisciplinary treatment of patients with esophageal cancer

Felice Mucilli, Chieti

16.20 Perspectives in the treatment of locally advanced/metastatic esophageal cancer Mario Roselli, Rome

16.40 Questions and answers

16.50 The actual role of neoadjuvant/perioperative and adjuvant treatments in early stages gastric cancer Carlo Garufi, Rome

17.10 Open issues: surgery in oligometastatic gastric cancer?

Maria Bencivenga, Verona

17.30 Metastatic gastric cancer: focus on targeted agents and checkpoint inhibitors

Alessandro Parisi, L’Aquila 17.50 Questions and answers 18.00 - 18:10

Concluding remarks 1° day

Corrado Ficorella, Clara Natoli & Nicola Tinari

Riferimenti

Documenti correlati

Medullary carcinoma: Medullary carcinoma of the breast is an invasive and uncommon form of breast cancer and has a prevalence of less than 5% of breast malignancies [48]..

Novel somatostatin-dopamine chimeric compound demonstrates superior efficacy in suppressing growth hormone secretion from human acromegalic tumors partially responsive to

The present review describes neuroendocrine neoplasms (NENs), a group of tumors originating from the neuroendocrine system deriving from digestive system and the

Finally, transfection studies utilizing human skin explants revealed an increase of cells producing protein from 2% with RNA alone to 12% with dendrimer polyplexes, attributed

In particular, every time that we have a CMV-like factorization for a matrix in terms of block unitary transformations, we can always perform a unitary transformation to obtain

b. 99m Tc sulfur colloid changing into albumin colloid c. increased uptake of colloid in the spleen and bone. marrow relative

Follow- ing the block removal method of evisceration, these structures will be present in all of the four main organ blocks with the submandibular sali- vary glands, tongue, and part

Pronounced thickening and increased enhancement of the soft palate ( arrows); the mass extends into the region of the retromolar trigone, and pushes the left lateral pharyngeal